Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: Primary 6-month results of the SAVE Study
Nguyen Q.D., Ibrahim M.A., Watters A., Bittencourt M., Yohannan J., Sepah Y.J., Dunn J.P., Naor J., Shams N., Shaikh O., Leder H.A., Do D.V.
View publication
-
Therapeutic Area
Back of the eye (BOTE)
-
Categories
Clinical development
-
Affiliations
Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street Maumenee 745, Baltimore, MD, United States; Santen Pharmaceuticals, Inc, Emeryville, CA, United States; Santen Pharmaceuticals, Osaka, Japan; Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, 3902 Leavenworth Street, Omaha, NE, United States